Published in Eur J Biochem on February 01, 1982
Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med (1995) 3.48
Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A (1996) 1.82
The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol (2009) 1.78
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med (2001) 1.75
Necrotic platelets provide a procoagulant surface during thrombosis. Blood (2015) 1.45
Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis". J Clin Invest (1996) 1.39
Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation. Proc Natl Acad Sci U S A (1989) 1.24
R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood (2008) 1.19
Coagulation initiated on herpesviruses. Proc Natl Acad Sci U S A (1997) 1.11
The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol (2010) 1.08
Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. J Clin Invest (1985) 1.08
New insights into the spatiotemporal localization of prothrombinase in vivo. Blood (2014) 1.03
Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase? Pflugers Arch (2013) 1.02
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ (2016) 1.01
Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J Cell Biol (1990) 1.01
Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem (2010) 0.97
The role of lectins and glycans in platelet clearance. J Thromb Haemost (2011) 0.95
Comparison between Ca2+-induced scrambling of various fluorescently labelled lipid analogues in red blood cells. Biochem J (2002) 0.95
WASP plays a novel role in regulating platelet responses dependent on alphaIIbbeta3 integrin outside-in signalling. Br J Haematol (2009) 0.94
A Pore Idea: the ion conduction pathway of TMEM16/ANO proteins is composed partly of lipid. Pflugers Arch (2016) 0.92
Vitamin K-dependent proteins in Ciona intestinalis, a basal chordate lacking a blood coagulation cascade. Proc Natl Acad Sci U S A (2006) 0.92
Erythrocyte morphology reflects the transbilayer distribution of incorporated phospholipids. J Cell Biol (1989) 0.89
Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine. Blood (2015) 0.89
A unique phospholipid organization in bovine erythrocyte membranes. Proc Natl Acad Sci U S A (2001) 0.87
Proline-rich Gla protein 2 is a cell-surface vitamin K-dependent protein that binds to the transcriptional coactivator Yes-associated protein. Proc Natl Acad Sci U S A (2007) 0.86
Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets. Circ Res (2014) 0.86
Phosphatidylserine in the brain: metabolism and function. Prog Lipid Res (2014) 0.85
The acceleration of the inhibition of platelet prothrombinase complex by heparin. Biochem J (1986) 0.84
Real-Time Live Confocal Fluorescence Microscopy as a New Tool for Assessing Platelet Vitality. Transfus Med Hemother (2010) 0.82
Resistance to UV-induced apoptosis in Chinese-hamster ovary cells overexpressing phosphatidylserine synthases. Biochem J (2004) 0.82
Agonist-induced platelet procoagulant activity requires shear and a Rac1-dependent signaling mechanism. Blood (2014) 0.82
[Thrombocytopathy and blood complications in uremia]. Wien Klin Wochenschr (2006) 0.81
Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides. Biochem J (1989) 0.80
Understanding the biosynthesis of platelets-derived extracellular vesicles. Immun Inflamm Dis (2015) 0.78
Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis. J Thromb Haemost (2011) 0.78
Collagen-stimulated unidirectional translocation of cholesterol in human platelet membranes. J Exp Biol (1999) 0.78
Facilitating roles of murine platelet glycoprotein Ib and alphaIIbbeta3 in phosphatidylserine exposure during vWF-collagen-induced thrombus formation. J Physiol (2004) 0.78
Phosphatidylserine (PS) Is Exposed in Choroidal Neovascular Endothelium: PS-Targeting Antibodies Inhibit Choroidal Angiogenesis In Vivo and Ex Vivo. Invest Ophthalmol Vis Sci (2015) 0.77
Virulence and thrombocyte affectation of two Aspergillus terreus isolates differing in amphotericin B susceptibility. Med Microbiol Immunol (2013) 0.76
Lipid nanotechnologies for structural studies of membrane-associated proteins. Proteins (2014) 0.76
Dynamic Nature of Thrombin Generation, Fibrin Formation, and Platelet Activation in Unstable Angina and Non-Q-Wave Myocardial Infarction. J Thromb Thrombolysis (1995) 0.76
Molecular characterisation of plasma membrane-derived vesicles. J Biomed Sci (2015) 0.76
Increased expression of procoagulant activity on the surface of human platelets exposed to heavy-metal compounds. Biochem J (1995) 0.75
Decoding P4-ATPase substrate interactions. Crit Rev Biochem Mol Biol (2016) 0.75
Infusible platelet membrane as a platelet substitute for transfusion: an overview. Blood Transfus (2013) 0.75
Platelet function and ageing. Mamm Genome (2016) 0.75
Phosphatidylserine Synthase Controls Cell Elongation Especially in the Uppermost Internode in Rice by Regulation of Exocytosis. PLoS One (2016) 0.75
Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression. Sci Rep (2016) 0.75
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet (1990) 6.54
The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim Biophys Acta (1973) 3.83
Localization of red cell membrane constituents. Biochim Biophys Acta (1973) 2.88
Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem (1990) 2.72
Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. Biochim Biophys Acta (1975) 2.42
The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem (1981) 2.39
The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem (1980) 2.39
Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci (2005) 2.32
The enzymatic synthesis of phosphatidylserine and purification by CM-cellulose column chromatography. Biochim Biophys Acta (1977) 2.14
A standard for low molecular weight heparin? Haemostasis (1989) 2.00
The adsorption of prothrombin to phosphatidylserine multilayers quantitated by ellipsometry. J Biol Chem (1983) 1.94
Lipid translocation across the plasma membrane of mammalian cells. Biochim Biophys Acta (1999) 1.93
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol (1997) 1.77
Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta (1983) 1.74
Lipid-protein interactions in blood coagulation. Biochim Biophys Acta (1998) 1.62
Membrane asymmetry and blood coagulation. Nature (1977) 1.57
Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost (1991) 1.55
Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase. Biochim Biophys Acta (1975) 1.53
Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim Biophys Acta (1986) 1.53
Organization of phospholipids in human red cell membranes as detected by the action of various purified phospholipases. Biochim Biophys Acta (1975) 1.53
Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets. Thromb Haemost (2001) 1.51
Lytic and non-lytic degradation of phospholipids in mammalian erythrocytes by pure phospholipases. Biochim Biophys Acta (1973) 1.45
Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol (1993) 1.42
The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif--the C-domain. J Thromb Haemost (2003) 1.39
Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis". J Clin Invest (1996) 1.39
Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet (1990) 1.38
Complete purification and some properties of phospholipase C from Bacillus cereus. Biochim Biophys Acta (1971) 1.35
Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta (1990) 1.34
A double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand (1967) 1.34
Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem (1985) 1.33
Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta (1991) 1.33
Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim Biophys Acta (1977) 1.31
Topological asymmetry of phospholipid metabolism in rat erythrocyte membranes. Evidence for flip-flop of lecithin. Eur J Biochem (1976) 1.29
Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol (1998) 1.28
Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood (1991) 1.28
Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem (1992) 1.27
Freeze-fracture appearance and disposition of band 3 protein from the human erythrocyte membrane in lipid vesicles. Eur J Biochem (1978) 1.26
The solubilization of human erythrocyte membranes by n-pentanol. Biochim Biophys Acta (1968) 1.25
Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem (1995) 1.22
[Autopsy in the middle ages]. Ned Tijdschr Geneeskd (1975) 1.22
Laboratory control of oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations. Thromb Diath Haemorrh (1970) 1.20
Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J Biol Chem (1983) 1.20
Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes. Biochemistry (1996) 1.19
Interactions between proteins and lipids from human red cell membranes. Chem Phys Lipids (1970) 1.19
The role of activated human platelets in prothrombin and factor X activation. Blood (1985) 1.19
Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem (1995) 1.17
Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake). J Biol Chem (1986) 1.17
Quantitation of infarct size in man by means of plasma enzyme levels. Br Heart J (1975) 1.17
Phospholipid scramblase activation pathways in lymphocytes. Biochemistry (2001) 1.15
Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry (1995) 1.15
Action of pure phospholipase A 2 and phospholipase C on human erythrocytes and ghosts. Biochim Biophys Acta (1971) 1.15
Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta (1978) 1.14
Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity. Biochemistry (1989) 1.12
Kinetic aspects of the interaction of blood clotting enzymes. 3. Demonstration of an inhibitor of prothrombin conversion in vitamin K deficiency. Thromb Diath Haemorrh (1968) 1.11
Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a rebuttal. J Thromb Haemost (2013) 1.10
Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. Evidence for an ATP-dependent and protein-mediated process. J Biol Chem (1992) 1.09
Heparin-like inhibitor, not vitamin-K deficiency, in the newborn. Lancet (1977) 1.08
Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry (1998) 1.08
Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. J Clin Invest (1985) 1.08
Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications. Lupus (1996) 1.06
The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost (2001) 1.06
Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol (2001) 1.06
Evidence for the preferential interaction of glycophorin with negatively charged phospholipids. Biochim Biophys Acta (1977) 1.05
Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol Cell Biochem (1990) 1.04